Contrary to expectations, at 12-month follow-up, there was no robust indication that PiP significantly reduced adolescent depression and anxiety symptoms as reported by either parents or adolescents, compared with the active-control intervention. This evidence concerns the gene PIP and depressive symptom measurement.